| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Fat emulsion |
Is a |
True |
Caloric agent (substance) |
Inferred relationship |
Some |
|
| Fructose agent |
Is a |
False |
Caloric agent (substance) |
Inferred relationship |
Some |
|
| Amino acid injection |
Is a |
False |
Caloric agent (substance) |
Inferred relationship |
Some |
|
| Carbohydrate agent |
Is a |
False |
Caloric agent (substance) |
Inferred relationship |
Some |
|
| Product containing glucose (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Caloric agent (substance) |
Inferred relationship |
Some |
|
| Glucose [endocrine] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Caloric agent (substance) |
Inferred relationship |
Some |
|
| Glucose 400 mg/g oral gel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Caloric agent (substance) |
Inferred relationship |
Some |
|
| Glucose-containing product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Caloric agent (substance) |
Inferred relationship |
Some |
|
| Fruktosepulver |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Caloric agent (substance) |
Inferred relationship |
Some |
|
| Gamolensyre |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Caloric agent (substance) |
Inferred relationship |
Some |
|
| Product containing precisely gamolenic acid 40 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Caloric agent (substance) |
Inferred relationship |
Some |
|
| Gamolenic acid 80 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Caloric agent (substance) |
Inferred relationship |
Some |
|
| Gamolensyre 80 mg pædiatrisk kapsel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Caloric agent (substance) |
Inferred relationship |
Some |
|
| natriumchlorid 0,225 %/glucose 5 % infusionsvæske, opløsning, pose |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Caloric agent (substance) |
Inferred relationship |
Some |
|
| sukrose 30 % øjendråber |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Caloric agent (substance) |
Inferred relationship |
Some |
|
| glucose 10 % infusionsvæske, opløsning, flaske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Caloric agent (substance) |
Inferred relationship |
Some |
|
| glucose 15 % infusionsvæske, opløsning i flaske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Caloric agent (substance) |
Inferred relationship |
Some |
|
| glucose 20 % infusionsvæske, opløsning i flaske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Caloric agent (substance) |
Inferred relationship |
Some |
|
| glucose 40 % infusionsvæske, opløsning i flaske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Caloric agent (substance) |
Inferred relationship |
Some |
|
| glucose 50 % infusionsvæske, opløsning i flaske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Caloric agent (substance) |
Inferred relationship |
Some |
|
| glucose 5 % infusionsvæske, opløsning i flaske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Caloric agent (substance) |
Inferred relationship |
Some |
|
| Fruktose 10 % infusionsvæske, opløsning, flaske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Caloric agent (substance) |
Inferred relationship |
Some |
|
| natriumchlorid 0,18 %/glucose 4 % infusionsvæske, opløsning, pose |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Caloric agent (substance) |
Inferred relationship |
Some |
|
| natriumchlorid 0,18 %/glucose 10 % infusionsvæske, opløsning, pose |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Caloric agent (substance) |
Inferred relationship |
Some |
|
| natriumchlorid 0,45 %/glucose 2,5 % infusionsvæske, opløsning, pose |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Caloric agent (substance) |
Inferred relationship |
Some |
|
| natriumchlorid 0,45 % + glucose 5 % infusionsvæske, opløsning, pose |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Caloric agent (substance) |
Inferred relationship |
Some |
|
| natriumklorid 0,9 %/glucose 5 % infusionsvæske opløsning, pose |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Caloric agent (substance) |
Inferred relationship |
Some |
|
| glucose 50 % injektionsvæske, opløsning i fyldt injektionssprøjte |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Caloric agent (substance) |
Inferred relationship |
Some |
|
| Product containing carbohydrate (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Caloric agent (substance) |
Inferred relationship |
Some |
|
| Product containing glucose and sodium chloride (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Caloric agent (substance) |
Inferred relationship |
Some |
|
| Fructose-containing product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Caloric agent (substance) |
Inferred relationship |
Some |
|
| glucose 70 % infusionsvæske, opløsning i pose |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Caloric agent (substance) |
Inferred relationship |
Some |
|
| Produkt bestående af essentielle fedtsyrer |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Caloric agent (substance) |
Inferred relationship |
Some |
|
| argininhydrochlorid 100 mg/ml injektionsvæske, opløsning, hætteglas a 100 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Caloric agent (substance) |
Inferred relationship |
Some |
|
| Dextrose 60g injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Caloric agent (substance) |
Inferred relationship |
Some |
|
| glucose 25 % opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Caloric agent (substance) |
Inferred relationship |
Some |
|
| Amino acids 10% injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Caloric agent (substance) |
Inferred relationship |
Some |
|
| Dextrose 5g/100mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Caloric agent (substance) |
Inferred relationship |
Some |
|
| Aminosyre, injektionsvæske, opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Caloric agent (substance) |
Inferred relationship |
Some |
|
| glucose 5 % injektionsvæske, opløsning, ampul |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Caloric agent (substance) |
Inferred relationship |
Some |
|
| Product containing fructose (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Caloric agent (substance) |
Inferred relationship |
Some |
|
| dekstrosepræparat |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Caloric agent (substance) |
Inferred relationship |
Some |
|
| kalorieholdigt middel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Caloric agent (substance) |
Inferred relationship |
Some |
|
| Product containing sucrose (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Caloric agent (substance) |
Inferred relationship |
Some |
|
| Product containing cysteine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Caloric agent (substance) |
Inferred relationship |
Some |
|
| cholestyramin + aspartam 4g/brev pulver |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Caloric agent (substance) |
Inferred relationship |
Some |
|
| stilbestrol 500 µg + mælkesyre 5 % vagitorium |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Caloric agent (substance) |
Inferred relationship |
Some |
|
| Cysteinhydrochlorid 50 mg/ml injektionsvæske, opløsning, ampul |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Caloric agent (substance) |
Inferred relationship |
Some |
|
| Cysteinhydrochlorid 50 mg/ml injektionsvæske, opløsning, ampul a 10 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Caloric agent (substance) |
Inferred relationship |
Some |
|
| Product containing lactic acid (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Caloric agent (substance) |
Inferred relationship |
Some |
|
| Product containing pectin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Caloric agent (substance) |
Inferred relationship |
Some |
|
| Product containing aspartame (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Caloric agent (substance) |
Inferred relationship |
Some |
|
| Product containing diethylstilbestrol and lactic acid (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Caloric agent (substance) |
Inferred relationship |
Some |
|
| Product containing alpha-glucosidase (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Caloric agent (substance) |
Inferred relationship |
Some |
|
| glucose 5 % i 0,2 % normalt saltvand |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Caloric agent (substance) |
Inferred relationship |
Some |
|
| kolestyramin + aspartam |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Caloric agent (substance) |
Inferred relationship |
Some |
|
| natriumchlorid 0,18 %/glucose 5 % infusionsvæske, opløsning, pose |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Caloric agent (substance) |
Inferred relationship |
Some |
|
| dekstrose 5 g/100 ml (5 %) injektionsvæske opløsning, hætteglas a 1000 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Caloric agent (substance) |
Inferred relationship |
Some |
|
| glucose 60 % i vand, infusionsvæske, opløsning, pose a 1000 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Caloric agent (substance) |
Inferred relationship |
Some |
|
| dekstrose 5 g/100 ml (5 %) infusionsvæske opløsning, hætteglas a 150 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Caloric agent (substance) |
Inferred relationship |
Some |
|
| glucose 25 % injektionsvæske til spædbørn, opløsning, hætteglas a 10 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Caloric agent (substance) |
Inferred relationship |
Some |
|
| glucose 5 g/100 ml (5 %) injektionsvæske, opløsning, hætteglas a 500 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Caloric agent (substance) |
Inferred relationship |
Some |
|
| glucose 60 % i vand, infusionsvæske, opløsning, pose a 500 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Caloric agent (substance) |
Inferred relationship |
Some |
|
| dekstrose 5 g/100 ml (5 %) iinjektionsvæske, opløsning, sprøjte a 10 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Caloric agent (substance) |
Inferred relationship |
Some |
|
| dekstrose 5 g/100 ml (5 %) injektionsvæske, opløsning, flaske a 150 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Caloric agent (substance) |
Inferred relationship |
Some |
|
| glucose 5 g/100 ml (5 %) injektionsvæske, opløsning, hætteglas a 25 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Caloric agent (substance) |
Inferred relationship |
Some |
|
| glucose 5 g/100 ml (5 %) injektionsvæske, opløsning, hætteglas a 100 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Caloric agent (substance) |
Inferred relationship |
Some |
|
| dekstrose 5 g/100 ml (5 %) injektionsvæske, opløsning, flaske a 250 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Caloric agent (substance) |
Inferred relationship |
Some |
|
| Aminosyrer 10 % injektionsvæske, opløsning, flaske a 500 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Caloric agent (substance) |
Inferred relationship |
Some |
|
| glucose 5 g/100 ml (5 %) injektionsvæske, opløsning, hætteglas a 50 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Caloric agent (substance) |
Inferred relationship |
Some |
|
| Lactic acid 50 mg/g and urea 100 mg/g cutaneous cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Caloric agent (substance) |
Inferred relationship |
Some |
|
| Lactic acid 250 mg/g and salicylic acid 250 mg/g cutaneous ointment |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Caloric agent (substance) |
Inferred relationship |
Some |
|
| salicylsyre + mælkesyre 16,7 %/16,7 % præparat til pensling |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Caloric agent (substance) |
Inferred relationship |
Some |
|
| bupivacain 0,5 % + glucose injektionsvæske, opløsning, ampul a 4 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Caloric agent (substance) |
Inferred relationship |
Some |
|
| bupivacain + glucose |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Caloric agent (substance) |
Inferred relationship |
Some |
|
| glucose 10 % infusionsvæske, opløsning i polyætylenflaske a 500 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Caloric agent (substance) |
Inferred relationship |
Some |
|
| glucose 10 % infusionsvæske, opløsning i polyætylenflaske a 1 l |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Caloric agent (substance) |
Inferred relationship |
Some |
|
| glucose 20 % infusionsvæske opløsning polyætylenflaske a 500 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Caloric agent (substance) |
Inferred relationship |
Some |
|
| glucose 20 % opløsning infusionsvæske i ampul a 20 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Caloric agent (substance) |
Inferred relationship |
Some |
|
| glucose 50 % opløsning, infusionsvæske, i ampul a 20 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Caloric agent (substance) |
Inferred relationship |
Some |
|
| glucose 50 % infusionsvæske, opløsning i hætteglas a 50 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Caloric agent (substance) |
Inferred relationship |
Some |
|
| glucose 50 % infusionsvæske, opløsning i pose a 500 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Caloric agent (substance) |
Inferred relationship |
Some |
|
| glucose 50 % infusionsvæske, opløsning, pose a 3 l |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Caloric agent (substance) |
Inferred relationship |
Some |
|
| glucose 50 % infusionsvæske, opløsning i polyætylenflaske a 500 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Caloric agent (substance) |
Inferred relationship |
Some |
|
| glucose 5 % infusionsvæske, opløsning i pose a 100 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Caloric agent (substance) |
Inferred relationship |
Some |
|
| glucose 5 % infusionsvæske, opløsning i pose a 150 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Caloric agent (substance) |
Inferred relationship |
Some |
|
| glucose 5 % infusionsvæske, opløsning i pose a 250 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Caloric agent (substance) |
Inferred relationship |
Some |
|
| glucose 5 % infusionsvæske, opløsning i pose a 1 l |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Caloric agent (substance) |
Inferred relationship |
Some |
|
| natriumchlorid 0,18 %/glucose 4 % infusionsvæske, opløsning, pose a 500 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Caloric agent (substance) |
Inferred relationship |
Some |
|
| natriumchlorid 0,18 %/glucose 4 % infusionsvæske, opløsning, pose a 1 l |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Caloric agent (substance) |
Inferred relationship |
Some |
|
| natriumchlorid 0,18 %/glucose 4 % infusionsvæske, opløsning, polyætylenflaske a 500 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Caloric agent (substance) |
Inferred relationship |
Some |
|
| natriumchlorid 0,9 %/glucose 5 % infusionsvæske, opløsning, pose a 500 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Caloric agent (substance) |
Inferred relationship |
Some |
|
| natriumchlorid 0,9 %/glucose 5 % infusionsvæske, opløsning, pose a 1 l |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Caloric agent (substance) |
Inferred relationship |
Some |
|
| natriumchlorid 0,9 %/glucose 5 % infusionsvæske, opløsning, polyætylenflaske a 500 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Caloric agent (substance) |
Inferred relationship |
Some |
|
| Gamolensyre 20 % creme |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Caloric agent (substance) |
Inferred relationship |
Some |
|
| Natlysolie 20 % creme |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Caloric agent (substance) |
Inferred relationship |
Some |
|
| jernsukrose 20 mg/ml injektionsvæske, opløsning, ampul a 5 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Caloric agent (substance) |
Inferred relationship |
Some |
|
| Product containing acesulfame potassium (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Caloric agent (substance) |
Inferred relationship |
Some |
|
| glucose 10 % opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Caloric agent (substance) |
Inferred relationship |
Some |
|
| glucose 20 % opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Caloric agent (substance) |
Inferred relationship |
Some |
|
| glucose 30 % opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Caloric agent (substance) |
Inferred relationship |
Some |
|
FHIR